economy
We're adding to an out-of-favor stock with limited exposure to Iran war upheaval
The stock has pulled back roughly 9% since the start of the conflict with Iran.
TL;DR
- Jim Cramer's Charitable Trust is buying 25 more shares of Cardinal Health (CAH).
- The trust's stake in CAH will increase to approximately 2.6% of the portfolio.
- Cardinal Health's business is primarily in the U.S. distributing pharmaceuticals and healthcare products, limiting exposure to geopolitical events like the conflict with Iran.
- The company is expected to see earnings per share grow by roughly 25% in its current fiscal year.
- Sales of GLP-1 medications have positively impacted the company's revenue growth.
- Gregory Kenny has retired as chairman of the board, replaced by Patricia Hemingway Hall; this was not due to disagreements with the company.
- Cardinal Health remains confident in its fiscal 2026 outlook and will report earnings on April 30.